Nonsteroidal anti-inflammatory drug-sparing effect of secukinumab in patients with radiographic axial spondyloarthritis: 4-year results from the MEASURE 2, 3 and 4 phase III trials (2021)
https://doi.org/10.1016/j.berh.2014.10.008 - DOI - PubMed

Disease activity outcome measures are only available in half of the electronic medical files of patients with axial spondyloarthritis followed in an outpatient clinic: the results of an audit of a tertiary-care rheumatology department (2021)
https://doi.org/10.1007/s00296-021-05055-3

Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA study (2021)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576480/